Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
34.46%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth34.46%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-31.41%
20%
—
—
Never
—
5 Years
Score—
Net Growth-31.41%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Galectin Therapeutics Inc fundamental performance
Across Galectin Therapeutics Inc's full reported history, from 2002 to 2025, net income went from -$ 3M to -$ 30M. Revenue increased in 0% of the years measured; net income in 39%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.14 | — |
1 Year2025-08-12 | $ 3.77 | -16.71% |
5 Years2021-08-12 | $ 3.55 | -11.55% |
10 Years2016-08-12 | $ 1.93 | 62.69% |
20 Years2006-08-11 | $ 10.08 | -68.85% |
All Time2002-09-09 | $ 12.00 | -73.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2002-09-09 |
|---|---|---|---|---|---|---|
| Price | $ 3.14 | $ 3.77 | $ 3.55 | $ 1.93 | $ 10.08 | $ 12.00 |
| Return | — | -16.71% | -11.55% | 62.69% | -68.85% | -73.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 30M | $ 17M |
| 2024 | $ 0.00 | -$ 47M | $ 15M |
| 2023 | $ 0.00 | -$ 41M | $ 25M |
| 2022 | $ 0.00 | -$ 38M | $ 18M |
| 2021 | $ 0.00 | -$ 30M | $ 39M |
| 2020 | $ 0.00 | -$ 23M | $ 27M |
| 2019 | $ 0.00 | -$ 13M | $ 47M |
| 2018 | $ 0.00 | -$ 13M | $ 8M |
| 2017 | $ 0.00 | -$ 16M | $ 3M |
| 2016 | $ 0.00 | -$ 21M | $ 15M |
| 2015 | $ 0.00 | -$ 20M | $ 25M |
| 2014 | $ 0.00 | -$ 15M | $ 29M |
| 2013 | $ 0.00 | -$ 12M | $ 10M |
| 2012 | $ 0.00 | -$ 9M | $ 9M |
| 2011 | $ 0.00 | -$ 10M | $ 6M |
| 2010 | -$ 5M | $ 5M | |
| 2009 | -$ 7M | $ 251K | |
| 2008 | -$ 3M | $ 318K | |
| 2007 | -$ 9M | $ 1M | |
| 2006 | -$ 3M | $ 5M | |
| 2005 | -$ 6M | $ 4M | |
| 2004 | -$ 7M | $ 10M | |
| 2003 | -$ 4M | $ 7M | |
| IPO2002 | -$ 3M | $ 1M |
Explore beyond GALT
You're looking at Galectin Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
